Literature DB >> 22107717

Lipids in liver disease: looking beyond steatosis.

Robert F Schwabe, Jacquelyn J Maher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22107717      PMCID： PMC4097005          DOI： 10.1053/j.gastro.2011.11.004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  20 in total

1.  Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.

Authors:  Tarek Moustafa; Peter Fickert; Christoph Magnes; Christian Guelly; Andrea Thueringer; Sasa Frank; Dagmar Kratky; Wolfgang Sattler; Helga Reicher; Frank Sinner; Judith Gumhold; Dagmar Silbert; Günter Fauler; Gerald Höfler; Achim Lass; Rudolf Zechner; Michael Trauner
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

Review 2.  The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.

Authors:  Anne Davit-Spraul; Emmanuel Gonzales; Christiane Baussan; Emmanuel Jacquemin
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

3.  PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.

Authors:  Ni-Huiping Son; Shuiqing Yu; Joseph Tuinei; Kotaro Arai; Hiroko Hamai; Shunichi Homma; Gerald I Shulman; E Dale Abel; Ira J Goldberg
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

4.  A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.

Authors:  Toshiaki Teratani; Kengo Tomita; Takahiro Suzuki; Tetsuya Oshikawa; Hirokazu Yokoyama; Katsuyoshi Shimamura; Susumu Tominaga; Sadayuki Hiroi; Rie Irie; Yoshikiyo Okada; Chie Kurihara; Hirotoshi Ebinuma; Hidetsugu Saito; Ryota Hokari; Kazuo Sugiyama; Takanori Kanai; Soichiro Miura; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2011-10-10       Impact factor: 22.682

5.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

Authors:  Kanji Yamaguchi; Liu Yang; Shannon McCall; Jiawen Huang; Xing Xian Yu; Sanjay K Pandey; Sanjay Bhanot; Brett P Monia; Yin-Xiong Li; Anna Mae Diehl
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

6.  Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population.

Authors:  George N Ioannou; Olivia B Morrow; Marah L Connole; Sum P Lee
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

7.  Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

Authors:  J J Smit; A H Schinkel; R P Oude Elferink; A K Groen; E Wagenaar; L van Deemter; C A Mol; R Ottenhoff; N M van der Lugt; M A van Roon
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

8.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

Review 9.  Cell biology of lipid droplets.

Authors:  Christoph Thiele; Johanna Spandl
Journal:  Curr Opin Cell Biol       Date:  2008-07-05       Impact factor: 8.382

10.  Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling.

Authors:  Maryam Rakhshandehroo; Linda M Sanderson; Merja Matilainen; Rinke Stienstra; Carsten Carlberg; Philip J de Groot; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964
View more
  10 in total

1.  The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet.

Authors:  Rashmi Pathak; Avinash Kumar; Henry A Palfrey; Laura A Forney; Kirsten P Stone; Narayan R Raju; Thomas W Gettys; Subramanyam N Murthy
Journal:  Inflamm Res       Date:  2019-05-09       Impact factor: 4.575

Review 2.  Hypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesity.

Authors:  David Aguilar; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

3.  Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis.

Authors:  Ricardo Moreno Traspas; Tze Shin Teoh; Pui-Mun Wong; Michael Maier; Crystal Y Chia; Kenneth Lay; Nur Ain Ali; Austin Larson; Fuad Al Mutairi; Nouriya Abbas Al-Sannaa; Eissa Ali Faqeih; Majid Alfadhel; Huma Arshad Cheema; Juliette Dupont; Stéphane Bézieau; Bertrand Isidor; Dorrain Yanwen Low; Yulan Wang; Grace Tan; Poh San Lai; Hugues Piloquet; Madeleine Joubert; Hulya Kayserili; Kimberly A Kripps; Shareef A Nahas; Eric P Wartchow; Mikako Warren; Gandham SriLakshmi Bhavani; Majed Dasouki; Renata Sandoval; Elisa Carvalho; Luiza Ramos; Gilda Porta; Bin Wu; Harsha Prasada Lashkari; Badr AlSaleem; Raeda M BaAbbad; Anabela Natália Abreu Ferrão; Vasiliki Karageorgou; Natalia Ordonez-Herrera; Suliman Khan; Peter Bauer; Benjamin Cogne; Aida M Bertoli-Avella; Marie Vincent; Katta Mohan Girisha; Bruno Reversade
Journal:  Nat Genet       Date:  2022-07-21       Impact factor: 41.307

4.  Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism.

Authors:  Caio Mateus Silva; Gustavo Duarte Ferrari; Luciane Carla Alberici; Osmar Malaspina; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2020-03-17       Impact factor: 3.396

Review 5.  Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.

Authors:  Mishghan Zehra; James C Curry; Sneha S Pillai; Hari Vishal Lakhani; Cory E Edwards; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

6.  Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.

Authors:  Camilla Schumacher-Petersen; Berit Østergaard Christoffersen; Rikke Kaae Kirk; Trine Pagh Ludvigsen; Nora Elisabeth Zois; Henrik Duelund Pedersen; Mogens Vyberg; Lisbeth Høier Olsen
Journal:  J Transl Med       Date:  2019-04-03       Impact factor: 5.531

7.  Cholesterol-induced inflammation and macrophage accumulation in adipose tissue is reduced by a low carbohydrate diet in guinea pigs.

Authors:  David Aguilar; Ryan C deOgburn; Jeff S Volek; Maria Luz Fernandez
Journal:  Nutr Res Pract       Date:  2014-11-01       Impact factor: 1.926

8.  Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis.

Authors:  Wei Hou; Wing-Kin Syn
Journal:  Front Cell Dev Biol       Date:  2018-11-12

Review 9.  High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway.

Authors:  Hyuk Moon; Kyungjoo Cho; Sunyeong Shin; Do Young Kim; Kwang-Hyub Han; Simon Weonsang Ro
Journal:  Int J Mol Sci       Date:  2019-01-29       Impact factor: 5.923

10.  Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.

Authors:  Sneha S Pillai; Hari Vishal Lakhani; Mishghan Zehra; Jiayan Wang; Anum Dilip; Nitin Puri; Kathleen O'Hanlon; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.